Physician profile
Mary E Emmick
NPI 1609218619
$887.94
in general payments reported to CMS, 2019-2025
9 companies · $5.97 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $19.40 · 2022: $332 · 2024: $247 · 2025: $5.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $202.88 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $179.17 | 2024 | |
| Allergan, INC. | $129.16 | 2019 | |
| Abbvie INC. | $115.51 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $89.40 | 2019 | |
| Lkc Technologies, INC. | $73.34 | 2024-2025 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Alcon Vision LLC | $13.12 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Emmick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.